Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

ERS Genomics

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Dublin, Ireland


Partners: Sumitomo Pharma

ERS Genomics is founded by Nobel prize winner Emanuelle Charpentier, and holds multiple patents to the CRISPR-Cas9 technology. The company has provided non-exclusive licenses for the use of CRISPR-Cas9 to many companies worldwide, although many remain undisclosed.


HashtagERS Genomics

Company: ERS Genomics
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine